April 2, 2008, Greenville, SC--Selah Technologies, an advanced materials manufacturer, has signed a license agreement with Clemson University for a multiphoton imaging technology, strengthening the company's nano-enabled product set.
The application for the new technology focuses on multiphoton fluorescence imaging and Selah Dots, carbon-based quantum dots that can be used for various applications, including life sciences, solar cells and anticounterfeiting, among others.
"Nanomaterials such as our Selah Dots have great potential to provide significant advances in the fight against cancer," says Andrew Metters, CTO of Selah Technologies. "In particular, multiphoton fluorescence imaging of specially functionalized Selah Dots will provide vital data such as the number and location of cancerous cells in a patient's body. In contrast to existing diagnostic methods, this information will be immediately available during treatment or surgery to enable physicians to precisely remove all diseased cells while maximizing retention of healthy tissue, thereby improving the survival rates and quality of life for cancer patients."
Clemson has filed for a US patent under the title "Photoluminescent Materials for Multiphoton Imaging."